Summary
45 / 100 · Bulios Score
What speaks for it
None of the indicators we track stands out on the positive side.
What to watch
- The company made a loss over the last 12 months.
- Operating profit does not even cover the interest on its debt.
- It missed profit estimates 5 times in the last 8 quarters.
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Score in detailPrice
Is it expensive?
Looks cheapThe company made a loss over the last 12 months, so there is no profit to set the price against.
Valuation in detailIs it growing?
SlowlyRevenue (USD)
Diluted EPS (USD)
- Analyst estimate
Revenue grew by 2.8% a year over the last 3 years. For the next fiscal year analysts expect revenue to grow by 0.7%.
Growth in detailDoes it make money?
PoorlyOver the last 12 months it made a loss of $169.0M.
Profitability in detailIs it financially healthy?
Debt is a burdenRepaying all its debt would take 32.8 years of free cash flow. Its debt is larger than its cash.
Financial health in detailDoes it pay a dividend?
Moderate, at risk- Yield
- 6.40%
- Raised in a row
- 1 year
You receive $2.13 per share a year. The payout is more than the company can comfortably cover.
Dividends in detailWhat do analysts expect?
Neutral- Buy 5
- Hold 8
- Sell 3
Today's price within the analysts' price targets
The average target of $43.75 is 24% above today's price. 31% of the analysts recommend buying.
Analysts in detailWhat does it earn on?
Fiscal year 2025By product
The company reports no revenue by product.
By region
- North America 41%
- UNITED STATES 38%
- Europe 13%
- Asia Pacific 4.9%
- CANADA 3.1%
- Other 0.1%
North America brings in 41% of revenue.
Segments in detail